drugset / Trial / NCT00606060
BAY14-2222 Continuous Infusion in Surgeries
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Phase III study, to evaluate the efficacy and safety of continuous infusion of rFVIII-FS in the treatment of patients with hemophilia A undergoing major elective surgery by achieving the required therapeutic concentrations.
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADVATE | Protein / enzyme biologic | 100 iu | — |
| Subject | ADVATE | Protein / enzyme biologic | 400 iu | — |